Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BIMEKIZUMAB-BKZX for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 3,059 adverse event reports in the FDA FAERS database where BIMEKIZUMAB-BKZX was used for Psoriasis.

Most Reported Side Effects for BIMEKIZUMAB-BKZX

Side Effect Reports % Deaths Hosp.
Product dose omission issue 694 13.0% 0 24
Psoriasis 621 11.6% 0 9
Drug ineffective 402 7.5% 0 11
Product availability issue 364 6.8% 0 17
Off label use 335 6.3% 3 39
Psoriatic arthropathy 301 5.6% 0 15
Injection site pain 263 4.9% 0 8
Therapy interrupted 252 4.7% 0 15
Hidradenitis 233 4.4% 0 14
Inappropriate schedule of product administration 214 4.0% 0 11
Incorrect dose administered 209 3.9% 0 5
Oral candidiasis 178 3.3% 0 9
Pain 159 3.0% 1 5
Fatigue 148 2.8% 0 6
Headache 146 2.7% 0 7

Other Indications for BIMEKIZUMAB-BKZX

Psoriatic arthropathy (1,033) Product used for unknown indication (716) Hidradenitis (598) Ankylosing spondylitis (199) Off label use (199) Axial spondyloarthritis (55) Rheumatoid arthritis (39) Dermatitis atopic (31) Illness (21) Pustular psoriasis (20)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

BIMEKIZUMAB-BKZX Full Profile All Psoriasis Drugs BIMEKIZUMAB-BKZX Demographics BIMEKIZUMAB-BKZX Timeline